ARCHIVES

Controversy Continues, Scientists, Advocates, Clinicians Say

This article is from The Cancer Letter archive.

Vol. 23 No. 04 | January 31, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: President’s Request For NCI FY 1981 Budget: Same As 1980; New Clinical Study Section Option Open

December 14, 1979

NCI Developing Policy On Relations Between Industry, DCT Clinical Trials

July 29, 1983

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

March 2, 2001

Reorganization Of Making Program Is Proposed

June 22, 1990

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007

FDA Proposes New Nonclinical Lab Regs

November 26, 1976